Market News

Canaccord Genuity analyst Sumant Kulkarni maintains Acadia Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $36 to $38.

The payments processor is navigating weak demand for travel to Europe, and softer sales at its restaurant and hotel customers.

What can we learn from the Oracle of Omaha?

Crescent Energy's Q3 earnings beat, rising Permian synergies and planned Devon acquisition bolster its upside potential, though debt and commodity ris...

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $40 to $30.

https://www.bloomberg.com/news/articles/2026-11-06/braskem-shareholders-pull-funding-offer-as-debt-talks-hit-snags

Revenue climbed on transit strength and a World Cup boost, with leverage easing.

Record profit came with a warning on veterinary cost inflation.

Chip stocks cratered while AMD's CEO stayed calm and told investors to think in years, not days. Her guidance looks bold, but a few risks, from regula...

Investing.com -- Tesla Inc (TSLA) is trading at $359.01, up 4.46%, as of Nov 6, 10:12 AM EST. The Cybertruck winddown means less about lost truck reve...

Elon Musk joined the ranks of billionaires largely on the back of his massive Tesla stake. Here’s how many shares he owns in the EV maker and how he a...

Is the AI trade over? These companies have double digit growth and are dirt cheap.

https://www.bloomberg.com/news/articles/2026-11-06/oil-traders-in-talks-with-us-to-get-sanctioned-ships-back-to-sea

One of industrials' steadiest dividend payers just broke into two stocks, and the math on your quarterly check may surprise you. One half carries heav...

Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Buy and raises the price target from $36 to $40.

AGEN's Q3 earnings meet estimates, but a revenue miss weighs on shares as pipeline progress, Armenian drug approvals and new funding emerge as key dev...

Blink posts its first positive adjusted EBITDA quarter, a milestone reached a quarter early.

Consumables returned to growth as a U.S. rental program takes shape.

Akamai Technologies' (AKAM) Q3 results were "solid," but a delay in its Cloud Infrastructure Service

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $45 to $42.